Literature DB >> 35788878

Increase recombinant antibody yields through optimizing vector design and production process in CHO cells.

Yongxiao Yang1,2, Zhengmei Li1,2, Qin Li2, Kai Ma2, Yan Lin2, Huigen Feng3, Tianyun Wang4.   

Abstract

Chinese hamster ovary (CHO) cells are the most commonly used host cells for the production of recombinant monoclonal antibodies (mAbs) due to their several advantages. Although the yields of recombinant mAbs can be greatly increased by some strategies, such as medium formulation, culture conditions, and cell engineering, most studies focused on either upstream design or downstream processes. In the present study, we first expressed recombinant adalimumab through combination of the vector design and production process optimization in CHO cells. Bicistronic vector, monocistronic vector, and dual promoter vector were constructed, and the production process was optimized using low-temperature and fed-batch culture. The results showed that the dual promoter vector exhibited the highest yield under the transient and stable transfected cells among three different vector systems in CHO cells. In addition, low-temperature and fed-batch culture could further improve the yields of adalimumab. The purified antibody displayed tumor necrosis factor-α (TNF-α) binding activity. In conclusion, combination of expression vector design and production process optimization can achieve higher expression of recombinant mAbs in CHO cells. KEY POINTS: • The dual promoter vector is more effective for expressing recombinant antibodies. • The yields of antibodies are related to the LC chain expression level. • Low-temperature and feed addition can promote antibody production.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Adalimumab; CHO cells; Production process; Purification and identification; Recombinant antibody; Vector optimization

Mesh:

Substances:

Year:  2022        PMID: 35788878     DOI: 10.1007/s00253-022-12051-5

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   5.560


  37 in total

1.  PhiC31 integrase can improve the efficiency of different construct designs for monoclonal antibody expression in CHO cells.

Authors:  Maryam Ahmadi; Fereidoun Mahboudi; Samira Ahmadi; Saeedeh Ebadat; Fatemeh Nematpour; Mohammad Reza Akbari Eidgahi; Fatemeh Davami
Journal:  Protein Expr Purif       Date:  2017-04-09       Impact factor: 1.650

Review 2.  Optimizing antibody expression: The nuts and bolts.

Authors:  B Vijayalakshmi Ayyar; Sushrut Arora; Shiva Shankar Ravi
Journal:  Methods       Date:  2017-02-02       Impact factor: 3.608

3.  Cleavage efficient 2A peptides for high level monoclonal antibody expression in CHO cells.

Authors:  Jake Chng; Tianhua Wang; Rui Nian; Ally Lau; Kong Meng Hoi; Steven C L Ho; Peter Gagnon; Xuezhi Bi; Yuansheng Yang
Journal:  MAbs       Date:  2015       Impact factor: 5.857

4.  Evaluation of different IRES-mediated tricistronic plasmid designs for expression of an anti-PCSK9 biosimilar monoclonal antibody in CHO cells.

Authors:  Thayana A Cruz; Marcos B Pinho; Leda R Castilho
Journal:  Biotechnol Lett       Date:  2020-07-16       Impact factor: 2.461

5.  Evaluation of different vector design strategies for the expression of recombinant monoclonal antibody in CHO cells.

Authors:  Hadi Bayat; Saghar Hossienzadeh; Eśhagh Pourmaleki; Roshanak Ahani; Azam Rahimpour
Journal:  Prep Biochem Biotechnol       Date:  2018-02-09       Impact factor: 2.162

Review 6.  Overview of Humira® Biosimilars: Current European Landscape and Future Implications.

Authors:  Jill Coghlan; Hongliang He; Anna S Schwendeman
Journal:  J Pharm Sci       Date:  2021-02-05       Impact factor: 3.534

7.  Engineering selection stringency on expression vector for the production of recombinant human alpha1-antitrypsin using Chinese Hamster ovary cells.

Authors:  Christine Lin Chin; Hing Kah Chin; Cara Sze Hui Chin; Ethan Tingfeng Lai; Say Kong Ng
Journal:  BMC Biotechnol       Date:  2015-06-02       Impact factor: 2.563

8.  Monoclonal antibodies expression improvement in CHO cells by PiggyBac transposition regarding vectors ratios and design.

Authors:  Samira Ahmadi; Fatemeh Davami; Noushin Davoudi; Fatemeh Nematpour; Maryam Ahmadi; Saeedeh Ebadat; Kayhan Azadmanesh; Farzaneh Barkhordari; Fereidoun Mahboudi
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

9.  Human rhinovirus internal ribosome entry site element enhances transgene expression in transfected CHO-S cells.

Authors:  Yu-Rong Chai; Meng-Meng Ge; Ting-Ting Wei; Yan-Long Jia; Xiao Guo; Tian-Yun Wang
Journal:  Sci Rep       Date:  2018-04-27       Impact factor: 4.379

10.  4-(2,5-Dimethyl-1H-pyrrol-1-yl)-N-(2,5-dioxopyrrolidin-1-yl) benzamide improves monoclonal antibody production in a Chinese hamster ovary cell culture.

Authors:  Yuichi Aki; Yuta Katsumata; Hirofumi Kakihara; Koichi Nonaka; Kenshu Fujiwara
Journal:  PLoS One       Date:  2021-04-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.